Navigation Links
Sharps Compliance Corp. Announces Purchase of Medical Waste Disposal Facility and Addition of Autoclave Technology
Date:1/23/2008

- Increases medical waste disposal capacity and capabilities to facilitate

growth plans

- New state-of-the-art autoclave technology provides environmentally

friendly operation - With the addition of the autoclave, one of approximately ten permitted commercial disposal facilities in the country capable of treating all types

of medical waste

- Opportunity for additional revenue streams

- Expanding ability to dispose of unused medications and expired

pharmaceutical waste, including controlled substances

HOUSTON, Jan. 23 /PRNewswire-FirstCall/ -- Sharps Compliance Corp. (OTC Bulletin Board: SCOM) ("Sharps" or the "Company"), leading providers of cost-effective disposal solutions for small quantity generators of medical waste, announced the purchase of its currently leased disposal facility in Carthage, Texas. The purchase includes an incinerator with a maximum capacity of thirty (30) tons per day, a 12,000 square foot building and 4.5 acres of land. The Company, through a subsidiary, has leased the facility since June of 2000. The facility is currently permitted to treat eleven (11) tons per day of waste.

Additionally, the Company has executed a purchase order for a state-of-the-art autoclave system and technology capable of treating up to seven (7) tons per day of medical waste at the same facility. Autoclaving is a process that treats medical waste with steam at high temperature and pressure to kill pathogens. An autoclave is environmentally cleaner and is a less costly method of treating most medical waste versus traditional incineration.

The new autoclave is capable of treating not only the Sharps Disposable by Mail System(R) products but also traditional medical waste from large quantity generators such as hospitals. The autoclave is expected to be operational by the summer of this calendar year. '/>"/>

SOURCE Sharps Compliance Corp.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Genta Receives Notice of Non-Compliance With NASDAQ Rule
2. Genta Receives NASDAQ Non-Compliance Notice
3. Siemens Building Technologies Helping Companies Participate in EPA Labs21 Movement With Comprehensive Compliance Solution Strategy
4. Genta Receives Notice of Non-Compliance with Listing Requirement for NASDAQ Global Market
5. NASDAQ Panel Grants Merge Technologies Additional Time to Regain Compliance
6. Vermillion, Inc. Announces Receipt Of Notice Of Compliance From Nasdaq
7. New White Paper Details Strategies for Biotechnology Companies to Improve EH&S Compliance
8. Pressure BioSciences, Inc. Announces CE Mark Approval and Compliance with the IEC 61010-1 Standard for a Second PCT-based Instrument, the Barocycler NEP2320
9. Sigma-Aldrich and Lab Manager Magazine Present Webinar On Laboratory Environmental, Health and Safety Compliance Strategies
10. FDA and Conformia Deliver Joint Presentation to Annual Regulatory and Compliance Symposium at Harvard
11. Ciphergen Biosystems Receives Noncompliance Letter From The Nasdaq Stock Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2008)...erica Technologies, Inc., a,growth-stage medical ...platforms for tissue regeneration, today announced...n, meeting stringent international quality standar... certification is the standard,recognized and acc... of an,effective quality system. The company,s le...
(Date:11/19/2008)...Call/ -- PharmAthene, Inc.,(NYSE Alternext US: PI...ermeasures against biological and chemical threats... with Medison Pharma Ltd., to commercialize its,b...or advanced medical countermeasures to combat the ...ical weapons is a significant global,concern," st...
(Date:11/19/2008)...wswire-FirstCall/ -- Bavarian Nordic,has invoiced...t of USD 25,million as allowed under the RFP-3 co...s of the company,s IMVAMUNE(R) smallpox vaccine. T... submission of a clinical safety report,from a la...d subjects, which,is part of the regulatory packa...
(Date:11/19/2008)...swire-FirstCall/ -- Cyprotex are,proud to announc...he most,sensitive ion trap and triple quadrupole ... 5500 LC-MS/MS offers unparalleled sensitivity and...sitive triple quadrupole with the,world,s most se...ombines,exceptional quantitative and qualitative ...
Breaking Biology Technology:Serica Technologies Receives ISO Certification, Meets International Standards for Medical Device Manufacturing 2Serica Technologies Receives ISO Certification, Meets International Standards for Medical Device Manufacturing 3Serica Technologies Receives ISO Certification, Meets International Standards for Medical Device Manufacturing 4PharmAthene Signs Agreement with Medison Pharma Ltd. to Commercialize and Distribute Biodefense Medical Countermeasures in Israel 2PharmAthene Signs Agreement with Medison Pharma Ltd. to Commercialize and Distribute Biodefense Medical Countermeasures in Israel 3PharmAthene Signs Agreement with Medison Pharma Ltd. to Commercialize and Distribute Biodefense Medical Countermeasures in Israel 4Bavarian Nordic Receives USD 25 Million Milestone Payment After Submission of Important IMVAMUNE(R) Data to The U.S. Health Authorities 2Cyprotex Purchases Applied Biosystems Sciex QTRAP(R) 5500 LC-MS/MS 2
..., CypHer5 TM is a red-excited, pH-sensitiv...d maximally fluorescent at pH 5.5. It is therefore...cell surface receptors via acidic endosomal vesicl...,>In the assay, the receptor can be epitope-tag...belled with CypHer5. Alternatively, an endogenous ...
...ds: adenoviral vector ● viral transduction ...delivery, , Biological assays deve...d secondary screening as well as lead and target v...challenges. Establishing stable cell systems to ex...s takes time. In addition, cellular signaling is c...
...ds: Melanocortin • receptor binding assay &b... , Pro-melanocortins are present in high le... major peptide hormone fragments: adrenocorticotro...and β-endorphin. The various melanocyte stimu...elanocortin subtype 5) receptor. The melanocortin ...
....K. Dhulipala 1 , Rao S. Takkellapati 1 , Kate Lav..., , 1 GE Healthcare, Piscataway, NJ, USA ..., University of Cambridge, Cambridge, UK , ...is of the two most commonly used methods for ampli...s. Ligation-mediated PCR is one of several current...
Other Biology Technology:The use of CypHer5 for receptor internalization studies in both a range of GPCRs and a non-GPCR 2The use of CypHer5 for receptor internalization studies in both a range of GPCRs and a non-GPCR 3The use of CypHer5 for receptor internalization studies in both a range of GPCRs and a non-GPCR 4The use of CypHer5 for receptor internalization studies in both a range of GPCRs and a non-GPCR 5The use of CypHer5 for receptor internalization studies in both a range of GPCRs and a non-GPCR 6Performance of Ad-A-Gene Cyclic AMP Response Element-Nitroreductase (CRE-NTR): an adenoviral vector gene delivery system 2Performance of Ad-A-Gene Cyclic AMP Response Element-Nitroreductase (CRE-NTR): an adenoviral vector gene delivery system 3Performance of Ad-A-Gene Cyclic AMP Response Element-Nitroreductase (CRE-NTR): an adenoviral vector gene delivery system 4Performance of Ad-A-Gene Cyclic AMP Response Element-Nitroreductase (CRE-NTR): an adenoviral vector gene delivery system 5Performance of Ad-A-Gene Cyclic AMP Response Element-Nitroreductase (CRE-NTR): an adenoviral vector gene delivery system 6Performance of Ad-A-Gene Cyclic AMP Response Element-Nitroreductase (CRE-NTR): an adenoviral vector gene delivery system 7Performance of Ad-A-Gene Cyclic AMP Response Element-Nitroreductase (CRE-NTR): an adenoviral vector gene delivery system 8The development of a melanocortin MC5 receptor binding assay using the LEADseeker Multimodality Imaging System 2The development of a melanocortin MC5 receptor binding assay using the LEADseeker Multimodality Imaging System 3The development of a melanocortin MC5 receptor binding assay using the LEADseeker Multimodality Imaging System 4The development of a melanocortin MC5 receptor binding assay using the LEADseeker Multimodality Imaging System 5GenomiPhi: protocol for BAC amplification and fabrication of slides for array CGH 2GenomiPhi: protocol for BAC amplification and fabrication of slides for array CGH 3GenomiPhi: protocol for BAC amplification and fabrication of slides for array CGH 4
(Date:11/19/2008)...earchers at Carnegie Mellon University,s Robotics ...grants from the U.S. Department of Agriculture (US... apple growers and one is for orange growers, but ...er production costs. , The systems use sensors o...thin the orchards to gather a multitude of data ab...
(Date:11/19/2008)... by a University of Central Florida professor show.... , Associate Professor James Turkson,s compound...r tumors in tests on mice. The compounds, S3I-201...called STAT3, and researchers have observed no neg...very promising," Turkson said. "They,ve worked ver...
(Date:11/18/2008)...ewswire-FirstCall/ -- Orchid Cellmark Inc.,(Nasda...ity DNA testing services,today reported its fina... Total revenues were $14.9 million for the thir...he third quarter of 2007. The decrease in total,... a year ago was largely due,to lower revenues in ...
(Date:11/18/2008)...e University of Pittsburgh have developed a simple...d dental samples, two substances at the center of ...chnique involves a fluorescent substance that glow...dized mercury, the researchers report in the curre...Chemical Society . The intensity of the glow indic...
Breaking Biology News(10 mins):Carnegie Mellon developing automated systems to enable precision farming of apples, oranges 2Carnegie Mellon developing automated systems to enable precision farming of apples, oranges 32 new compounds show promise for eliminating breast cancer tumors 2Orchid Cellmark Reports Third Quarter 2008 Financial Results 2Orchid Cellmark Reports Third Quarter 2008 Financial Results 3Orchid Cellmark Reports Third Quarter 2008 Financial Results 4Orchid Cellmark Reports Third Quarter 2008 Financial Results 5Orchid Cellmark Reports Third Quarter 2008 Financial Results 6Orchid Cellmark Reports Third Quarter 2008 Financial Results 7Orchid Cellmark Reports Third Quarter 2008 Financial Results 8Pitt researchers use fluorescence to develop method for detecting mercury in fish 2Scientists in Japan design first optical pacemaker for laboratory research 20350 1Most developing countries ill equipped to ensure global biosafety 3A UN University 5652 1Most developing countries ill equipped to ensure global biosafety 3A UN University 5652 2Most developing countries ill equipped to ensure global biosafety 3A UN University 5652 3Weizmann Institute scientists create new nanotube structures 5650 1Weizmann Institute scientists create new nanotube structures 5650 2AUDIO from Medialink and Merck 3A Women Unite to Fight Cervical Cancer 20348 1
...cal,detection by factor of 10 billion,New research...emy of,Science finds that tailored nanoparticles k... as much as 10 billion times. That makes,them abou...than,traditional methods. , When,molecules and mat...t,interacts in such a way that it allows scientist...
...-chip", i.e., integrated chemical and biochemical ... chip. An essential prerequisite for such labs are... of very small amounts of liquids and chemical rea... can be fabricated by available photolithographic ...or such microcompartments and, thus, provide a new...
...ne (Ed : testosterone isn,t a protein, it,s a ste... shape that allows it to function properly. Now St...le test that instantly changes color when a protei...r unfolds. The new technique, which works on the s...e acidity of water, is described in the March 2005...
...an be genetically modified to brandish a powerful ...ck and kill leukemic cells. This finding, from res... suggests a way to improve the outcome of children...kemia (ALL) or other blood cancers. , Results of ...line issue of Blood. , The researchers demonstrate...
Other Biology News:Study shows nanoshells ideal as chemical nanosensors 2Open microfluidic and nanofluidic systems 2Open microfluidic and nanofluidic systems 3Open microfluidic and nanofluidic systems 4Scientists develop new color-coded test for protein folding 2Genetically modified natural killer immune cells attack, kill leukemia cells 2
p38 MAP Kinase gamma Antibody Shipping Temperature: HOT Storage Temperature: -20C
Chicken polyclonal to HAGH ( Abpromise for all tested applications). Antigen: Synthetic peptide, corresponding to N terminal amino acids 110-260 of Human HAGH. Entrez GeneID: 3029 Swiss
Anti-FLIPgamma / delta (CT) Antibody, Unconjugated from QED Bioscience Inc.
Phospho- (Ser) 14-3-3 Binding Motif (4E2) Mouse mAb
Biology Products: